| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/28/2009 | US7566717 Substituted heterocyclic compounds |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566712 Biaryl piperazinyl-pyridine analogues |
| 07/28/2009 | US7566683 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/28/2009 | CA2370147C Piperidine-indole compounds having 5-ht6 affinity |
| 07/23/2009 | WO2009091884A1 High dielectric constant liquid crystal |
| 07/23/2009 | WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091732A1 Compounds for the treatment of metabolic disorders |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009091291A1 N-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5h-pyrimidinesulfone)-isonicotinoyl hydrazide silver salt |
| 07/23/2009 | WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| 07/23/2009 | WO2009090414A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | WO2009090039A1 Pyridazine fungicides |
| 07/23/2009 | WO2009089851A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | WO2009089659A1 Pyrollidine-based compounds |
| 07/23/2009 | WO2009071690A3 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009071689A3 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009066317A3 Process for the preparation of pantoprazole sodium |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | WO2009061875A3 Processes and intermediates for producing aminobenzimidazole ureas |
| 07/23/2009 | WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 07/23/2009 | WO2009038759A3 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 07/23/2009 | WO2009023664A3 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 07/23/2009 | WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 07/23/2009 | WO2009005671A3 Substituted piperazines as cb1 antagonists |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates |
| 07/23/2009 | WO2008090412A3 Proton conducting aromatic polyether polymers with pyridinyl side chains for fuel cells |
| 07/23/2009 | WO2008061796A3 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 07/23/2009 | US20090187023 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl))-piperidine-2,6-dione |
| 07/23/2009 | US20090187021 Indane compounds as ccr5 antagonists |
| 07/23/2009 | US20090186924 Substituted arylpyrazoles |
| 07/23/2009 | US20090186923 Compounds Having CRTH2 Antagonist Activity |
| 07/23/2009 | US20090186922 2-arylindole derivatives as npges-i inhibitors |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186918 Triazole Compounds as Lipoxygenase Inhibitors |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186912 Anti-infective agents and uses thereof |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 07/23/2009 | US20090186904 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof |
| 07/23/2009 | US20090186897 Phthalazinone derivatives |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186894 N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use |
| 07/23/2009 | US20090186881 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/23/2009 | US20090186876 Pyridine Analogues II |
| 07/23/2009 | US20090186875 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer |
| 07/23/2009 | US20090186874 Carboxamide derivative and use thereof |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186869 Antiviral compounds |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/23/2009 | US20090186155 Ink for ink-jet recording, ink cartridge, ink-jet recording apparatus, method of determining, and method of ink-jet recording |
| 07/23/2009 | US20090184630 Novel condensed ring aromatic compound and organic light-emitting device having the same |
| 07/23/2009 | US20090184313 Materials for organic electroluminescent devices |
| 07/23/2009 | CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712017A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | CA2711514A1 Pyridazine fungicides |
| 07/23/2009 | CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | EP2080759A1 Gama-globin inducer |
| 07/22/2009 | EP2080758A2 Halogen substituted delta-1-pyrrolines |
| 07/22/2009 | EP2080757A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 07/22/2009 | EP2079736A1 Substituted triazoles useful as axl inhibitors |
| 07/22/2009 | EP2079735A1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
| 07/22/2009 | EP2079731A1 Novel substituted piperidyl-propane-thiols |
| 07/22/2009 | EP2079730A1 Mglur5 modulators |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079728A1 N-aryl pyrazole compounds for use against diabetes |
| 07/22/2009 | EP2079727A2 Kinase inhibitor compounds |
| 07/22/2009 | EP2079726A2 Substituted amides, method of making, and method of use thereof |
| 07/22/2009 | EP2079725A1 Piperidyl-propane-thiol ccr3 modulators |
| 07/22/2009 | EP2079724A2 Substituted pyridone compounds and methods of use |
| 07/22/2009 | EP2079703A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 07/22/2009 | EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2009 | EP2079699A1 Quinoline derivatives |
| 07/22/2009 | EP2079695A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 07/22/2009 | EP2079693A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 07/22/2009 | EP2079485A2 Phenylpropionamide compounds and the use thereof |
| 07/22/2009 | EP1877052B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/22/2009 | EP1828166B1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | EP1667996B1 Quinazoline derivatives |
| 07/22/2009 | EP1646610B1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1458413B1 Pharmaceutical compositions based on azetidine derivatives |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490038A Pyrimidine derivatives as ALK-5 inhibitors |
| 07/22/2009 | CN101490037A Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 07/22/2009 | CN101490036A Factor XA inhibitors |
| 07/22/2009 | CN101490035A Amino-piperidine derivatives as CETP inhibitors |
| 07/22/2009 | CN101490034A Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | CN101490033A 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 07/22/2009 | CN101486706A Omeprazole sodium compound and method for synthesizing the same |
| 07/22/2009 | CN101486705A Preparation of Azelnidipine alpha crystal form |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |